BEIJING, Aug. 28, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Bioph...
BEIJING, Aug. 18, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Bioph...
BEIJING, July 8, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (the "Company"), a...
Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING, April 23, 20...
* Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2% YoY * Achieved gros...